Buy Gilead Sciences, JD.Com And Sell Atossa Genetics – Top RSI Trades For Today – Amigobulls

Day Trading Ideas, RSI overbought/oversold signals - Buy Gilead Sciences, Inc. (GILD) stock, JD.Com Inc(ADR) (JD) stock and sell Atossa Genetics Inc (ATOS) stock.

Here is a summary of today's top day trading ideas based on popular momentum indicator Relative Strenght Index (RSI). The RSI indicator can be used to identify buy/sell signals in the market and today's most popular stocks flashing buy/sell signals using RSI indicator include Foster City, California-basedbiotech company Gilead Sciences (NASDAQ:GILD), Chinese e-commerce company JD.com (NASDAQ:JD) and Seattle-based healthcare firmAtossa Genetics (NASDAQ:ATOS). If you want to see the complete set of technical tradingideas for todaycheck them out here.

Shares of Gilead Sciences have failed to sustain the rally after theQ2 2017 earnings release in the last week of July. In the month of August, GILD stock has gradually trended downwards and is down nearly 5%. Investors would be hoping for a rebound soon, as the companyseems to be getting things sorted, posting better than expected earnings in the second quarter. The GILD stock may soon end its downward trend, as theas the stock is in oversold territory. The RSI indicator is flashing an oversold signal for Gilead stock. The RSI value of the stock has fallen to 27.22, which is below the commonly use oversold RSI measure of 30. The rebound in Gilead shares couldget a further boost by the fact that the share price is very close to the lower Bollinger Band, implying that the indicator could flash an oversold signal as well. A rebound in Gilead shares is most likely around the corner.

Shares of JD.Com have had an amazing year, rising by a whopping 89% until last week. From August 9th, JD stock has been trending downwards going into its earnings. In spite of the massive correction of more than 14%, the stock is up more than 60% in the Year-to-Date. JD.com delivered better than expected results in its Q2 earnings, but the downward pressure increased on account of widened Q2 losses. However, it might be time to buy JD stock again. The fundamental story of JD has not changed much, as the company has forecasted strong revenue growth of36% to 40%for the third quarter. Popular momentum indicators like RSI and Bollinger Bands are both flashing an oversold signal. The RSI value of the stock stands at 29.87, just below the common oversold threshold measure of 30. For JD.Com stock, the Bollinger Bands indicator is also flashing an oversold signal. The share price of the company has already fallen below the lower Bollinger Band to flash an oversold signal. This further increases the probability that JD stock may soon resume its uptrend. The combination of the above two signals is considered as a strong signal.

Looking for fundamentally better tech stocks? Check out Amigobulls'top stock picksfrom the tech sector, which have beaten the NASDAQ by over 140%. Interested in automotive stocks? Then, we also have ourtop picks from the auto sector, which have beaten the S&P 500 by a massive 234%.

Originally posted here:
Buy Gilead Sciences, JD.Com And Sell Atossa Genetics - Top RSI Trades For Today - Amigobulls

Seattle Genetics’ Adcetris Granted Priority Review by FDA – Nasdaq

Seattle Genetics, Inc. SGEN announced that the FDA has accepted its supplemental Biologics License Application (BLA) for Adcetris (brentuximab vedotin) in patients with cutaneous T-cell lymphoma (CTCL). Additionally, the FDA granted Priority Review for the application and has set a target action date of Dec 16, 2017.

Adcetris is the only marketed product at Seattle Genetics. The drug is approved for relapsed Hodgkin lymphoma and relapsed systemic anaplastic large cell lymphoma (sALCL) in the U.S., the EU and Japan. It is also approved in the U.S. for the treatment of patients suffering from classical Hodgkin lymphoma, who are at high risk of relapse or progression as post-autologous hematopoietic stem cell transplantation (auto-HSCT) consolidation.

Notably, shares of the company have declined 11.4% against the Zacks classified industry's gain of 7.4% on a year-to-date basis.

The submission of the supplemental BLA was mainly based on positive data from the phase III trial, ALCANZA and two phase II investigator-sponsored trials in patients with CTCL. Interestingly, the ALCANZA study achieved both the primary and secondary endpoints.

The study showed that CTCL patients treated with Adcetris had superior outcomes across all primary and secondary endpoints compared with patients in the control arm, who were treated with either methotrexate or bexarotene standard of care agents.

Furthermore, the FDA granted Breakthrough Therapy Designation (BTD) to Adcetris for the treatment of patients with CD30-expressing mycosis fungoides and primary cutaneous anaplastic large cell lymphoma, who require systemic therapy and have received one prior systemic therapy in November 2016.

Adcetris, generated revenues of $74.3 million, up 12.3% year over year in the second quarter of 2017 and is expected to generate sale in the range of $290 million to $310 million in the U.S. and Canada in 2017. Seattle Genetics is also working on expanding the drug's label which will be a further boost for the company's revenues.

Seattle Genetics, Inc. Price

Seattle Genetics, Inc. Price | Seattle Genetics, Inc. Quote

Zacks Rank & Stocks to Consider

Seattle Genetics currently holds a Zacks Rank #3 (Hold). Some better-ranked stocks in health care sector include Alexion Pharmaceuticals, Inc. ALXN , Regeneron Pharmaceuticals, Inc. REGN and Sanofi SNY . While Alexion and Regeneron sport a Zacks Rank #1 (Strong Buy), Sanofi holds Zacks Rank #2 (Buy). You can see the complete list of today's Zacks #1 Rank stocks here .

Alexion Pharmaceuticals' earnings per share estimates have moved up from $4.55 to $4.77 for 2017 and from $5.49 to $6.43 for 2018 over the last 30 days. The company delivered positive earnings surprises in three of the trailing four quarters, with an average beat of 12.26%. The share price of the company has increased 11.7% year to date.

Regeneron's earnings per share estimates have increased from $10.52 to $13.81 for 2017 and from $12.10 to $14.54 for 2018 over the last 30 days. The company pulled off positive earnings surprises in two of the trailing four quarters, with an average beat of 6.29%. The share price of the company has increased 27.6% year to date.

Sanofi's earnings per share estimates have moved up from $3.20 to $3.31 for 2017 and from $3.36 to $3.38 for 2018 over last 30 days. The company came up with positive earnings surprises in three of the trailing four quarters, with an average beat of 5.10%. The share price of the company has increased 19.7% year to date.

One Simple Trading Idea

Since 1988, the Zacks system has more than doubled the S&P 500 with an average gain of +25% per year. With compounding, rebalancing and exclusive of fees, it can turn thousands into millions of dollars. This proven stock-picking system is grounded on a single big idea that can be fortune shaping and life changing. You can apply it to your portfolio starting today. Learn more >>

Alexion Pharmaceuticals, Inc. (ALXN): Free Stock Analysis Report

Regeneron Pharmaceuticals, Inc. (REGN): Free Stock Analysis Report

Seattle Genetics, Inc. (SGEN): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Original post:
Seattle Genetics' Adcetris Granted Priority Review by FDA - Nasdaq

Cancer Genetics pays $12M for Australian CRO vivoPharm – FierceBiotech

U.S. oncology specialist Cancer Genetics will pay $12 million to buy out Australian contract research organization vivoPharm as it looks to bolster its offerings.

Cancer Genetics (CGI) says the deal will boost its position as a premier leader for oncology discovery, in vivo and in vitro drug development and early phase clinical trial testing for biotechnology and pharmaceutical companies.

It buys into vivoPharm, a firm that has spent 10 years offering discovery and preclinical services to support drug development, target validation and biomarker analysis, with a big focus on immuno-oncology.

The CRO currently works with more than 40 biopharmas across five continents, in more than 55 studies and trials. Its led by Ralf Brandt, who will be fully integrated as the flagship in CGIs discovery services offering, according to its new owner, serving as the president of this unit.

The deal closed this week, and sees its 32 staffers subsumed into CGI. The price paid, $12 million, includes $1.2 million in cash, with the remaining 90% in the form of shares of CGI common stock. The company has also signed an equity financing deal for up to $16 million to fund the takeover.

The acquisition is expected to be immediately accretive, adding both revenue and income, CGI said in a statement.

The combination of capabilities is expected to create considerable business opportunities in both pre-clinical studies and immuno-oncology clinical trials, to further accelerate CGIs strategy to be the premier partner of choice for oncology innovation and development from bench to bedside.

More:
Cancer Genetics pays $12M for Australian CRO vivoPharm - FierceBiotech

Re AK, Human Fertilisation and Embryology Act 2008 [2017] EWHC 1154 (Fam)-1 – Family Law Week

Home > Judgments

Case summary coming soon

This judgment was handed down in open court

Case numbers omitted Neutral Citation Number: [2017] EWHC 1154 (Fam)

IN THE HIGH COURT OF JUSTICEFAMILY DIVISIONRoyal Courts of JusticeStrand, London, WC2A 2LL

Date: 28 July 2017

Before :

SIR JAMES MUNBY PRESIDENT OF THE FAMILY DIVISION- - - - - - - - - - - - - - - - - - - - -

In the Matter of the Human Fertilisation and Embryology Act 2008(Case AK)- - - - - - - - - - - - - - - - - - - - -- - - - - - - - - - - - - - - - - - - - -

Mr Dorian Day (instructed by Jennings Solicitors) for the applicantMs Marlene Cayoun (instructed by DAC Beachcroft LLP) for Care Fertility Northampton

Hearing date: 21 July 2017 - - - - - - - - - - - - - - - - - - - - -

Judgment Sir James Munby, President of the Family Division : 1.Since I handed down judgment in In re A and others (Legal Parenthood: Written Consents) [2015] EWHC 2602 (Fam), [2016] 1 WLR 1325, I have had to consider a number of cases raising issues very similar to the issue which confronts me here. The most recent judgment was Re the Human Fertilisation and Embryology Act 2008 (Cases AD, AE, AF, AG and AH) [2017] EWHC 1026 (Fam). They were the thirtieth to thirty-fourth of these cases in which I have given a final judgment. This judgment relates to another case, Case AK. Two other cases, Cases AI and AJ, are pending. That makes thirty-seven cases in all.

2.For the purposes of this judgment I shall take as read the analysis in In re A and the summary of the background to all this litigation which appears in Re the Human Fertilisation and Embryology Act 2008 (Case O) [2016] EWHC 2273 (Fam). The facts3.For reasons which will by now be familiar, I propose to be extremely sparing in what I say of the facts and the evidence in this case.

4.The applicant is a woman. She was neither in a civil partnership with nor married to the respondent mother. The case relates to treatment provided by Care Fertility Northampton, a clinic regulated by the Human Fertilisation and Embryology Authority. I shall refer to the applicant as X, the respondent as Y and the child as C. X seeks a declaration pursuant to section 55A of the Family Law Act 1986 that she is, in accordance with sections 43 and 44 of the Human Fertilisation and Embryology Act 2008, the legal parent of C. Although they are now separated, Y is wholeheartedly supportive of X's application. The clinic, the HFEA, the Secretary of State for Health and the Attorney General have all been notified of the proceedings. None has sought to be joined, though the clinic attended the hearing in the person of its "person responsible" and was represented by counsel. Given the nature of the issue (see below) I decided that there was no need for C to have a guardian appointed.

5.I heard the case on 21 July 2017. X was represented by Mr Dorian Day, the clinic by Ms Marlene Cayoun. Y was not present but had sent a handwritten letter to the court dated 18 July 2017 "to confirm my support for the applicant, in the hearing to obtain parental status for our [child]." The letter, having explained why she could not be present, went on:

"[X] has my full support and backing in this case. I hope in court on Friday this terrible error by Care Northampton is rectified and we can start to move on from all the stress and upset it has caused."

6.X was present in court. There was, in view of the conclusion I had come to, no need for X to give oral evidence but in accordance with my invariable practice in these cases (see Re the Human Fertilisation and Embryology Act 2008 (Cases AD, AE, AF, AG and AH) (No 2) [2017] EWHC 1782 (Fam), para 12) I asked X if she wanted to speak. She did so from the well of the court I saw no need for her to be sworn. Her words, though brief, were powerful and very moving; for some of the time she was in tears, and I can well understand why.

7.I need at this point to go back a little. On 27 June 2017, the "person responsible" at the clinic made a witness statement, in the course of which she offered "my unreserved apology to [X] and [Y] for this error both personally and on behalf of Care Fertility Northampton" and went on "to express my sincerest apologies on behalf of Care Fertility Northampton and Care Fertility Group generally, for the distress that this matter has inevitable caused [X, Y and C]."

8.X responded in a witness statement dated 13 July 2017. I deliberately do not set out the more personal matters it deals with, but there are two aspects to which I think I should draw attention. The first relates to the impact on X of discovering that there was a question over her parentage of C:

" when I was made aware of the fact that I legally had no rights in respect of [C] due to a significant error by the CARE Fertility Group Limited (CFGL), my whole world was turned upside down and this obviously had a significant effect on me and my ability to cope with life generally on a day to day basis.

I was completely unable to deal with being told that I had not legal rights of parentage in respect of my [child]. I know that [C] wouldn't understand this or wouldn't view me any differently but that didn't change how it had made me feel. I felt that I was an inferior person in [C]'s life so far as the outside world was concerned. I felt that the confidence that I had been given in the change in the law to allow same sex couples to have children and be considered legal parents had been snatched away from me. I simply felt that I was no more than a step parent to [C] rather than [C's] actual parent who had been involved in every part of [C's] life from deciding to have [C], the fertility process, [C's] birth and then upbringing.

A declaration from the court cannot take away the hurt and distress that I have felt from the moment that I found out about this issue until it will have been resolved, it also cannot undo the ongoing effects that this situation has caused "

9.The second relates to her reaction to the witness statement from the clinic:

"Despite all that I have been through emotionally in this matter I felt that the CFGL empathised and understood how their negligent error had effected me and that they only wanted to assist me in putting matters right. However, having read the statement prepared on behalf of the clinic by , I don't believe that they have any understanding whatsoever about how this has affected me or the gravity of their mistake. Yes they accept in the statement that they made a mistake but they seem to somewhat try to pass it off as insignificant and non consequential in terms of the effect that this has had on me. I felt sick to my stomach when I read the statement because I felt that they, of all people, would have at least recognised the harm and upset that they would have caused."

10.She concluded:

"The reality is that this has had a massive traumatic and financial effect on my life."

In the light of the rest of her evidence, I am quite satisfied that this is no exaggeration on X's part.

11.Before me, in court, X explained the effect all this had had on her relationship with Y, on her job and, worst of all, on her relationship with C.

12.I draw attention to these matters not so much to criticise the clinic, whose attitude throughout this case has been very significantly better than in a number of other cases where criticism has been merited, but to bring out not for the first time, I have to say the devastating effects these errors and the subsequent litigation have on the parents blamelessly and unwillingly caught up in the process. I am not surprised that X should have used the word "traumatic." It describes, unhappily but all too accurately, the impacts on them which have been described to me by so many parents in these cases. I venture to repeat again what I said in Re the Human Fertilisation and Embryology Act 2008 (Case G) [2016] EWHC 729 (Fam), para 32:

"If ever there was a situation calling for empathy, understanding, humanity, compassion and, dare one say it, common decency, never mind sincere and unqualified apology, it is surely this."

13.At the end of the hearing I indicated that I was making the order sought. I now (28 July 2017) hand down judgment explaining my reasons.

14.Although I am acutely conscious of the stress, worry and anxiety burdening parents in these cases, and of the powerful human emotions that are inevitably engaged, this case is, in terms of the applicable legal analysis, straight-forward and simple, though on the facts it raises a novel point. The evidence, which there is no need for me to rehearse in detail, is compelling. The answer, at the end of the day, is, in my judgment, clear.

15.Just as in each of the other cases I have had to consider, so in this case, having regard to the evidence before me, I find as a fact that:

i)The treatment which led to the birth of C was embarked upon and carried through jointly and with full knowledge by both the woman (that is, Y) and her partner (X).

ii)From the outset of that treatment, it was the intention of both X and Y that X would be a legal parent of C. Each was aware that this was a matter which, legally, required the signing by each of them of consent forms. Each of them believed that they had signed the relevant forms as legally required and, more generally, had done whatever was needed to ensure that they would both be parents.

iii)From the moment when the pregnancy was confirmed, both X and Y believed that X was the other parent of the child. That remained their belief when C was born.

iv)X and Y, believing that they were entitled to, and acting in complete good faith, registered the birth of their child, as they believed C to be, showing both of them on the birth certificate as C's parents, as they believed themselves to be.

v)The first they knew that anything was or might be 'wrong' was when, some years later, they were contacted by the clinic.

16.I add that there can be no suggestion that any consent given was not fully informed consent. Nor is there any suggestion of any failure or omission by the clinic in relation to the provision of information or counselling.The issue17.Adopting the terminology I have used in previous cases, the problem in this case is very shortly stated. The Form WP was correctly completed by Y. There is no Form PP that can be found. It is not clear whether this is because there never was a Form PP or because the Form PP has been lost, but the case is not put forward on the basis that I can find that a properly completed Form PP has been lost. Nor does there seem ever to have been a Form IC.

18.The Form WP was, as I have said, properly completed by Y. Y's name and date of birth appear in section 1 ("About you"). X's name and date of birth appear in section 2 ("About your partner"). The consent box in section 3 on the second page ("Your consent to your partner being the legal parent") was ticked. Y signed the declaration in section 4.

19.Immediately following that signature, and the date of signature, the printed form contains the following text:

"If signing on behalf of the person consenting

If the person consenting is unable to sign for themselves because of illness, injury or physical disability, someone else representing the person can sign the form on their behalf. There must also be a witness confirming that the person consenting is present when the representative signs the form.Representative's declaration

I declare that the person named in section 1 of this form is present at the time of signing this form."

Adjacent to the words "Representative's name" there is a box in which Y had written X's name. Adjacent to the words "Representative's signature" there is another box which contains X's signature. Adjacent to the words "Relationship to the person consenting" there is another box in which Y had written the word "Partner". This part of the form bears the same date as the previous part. Both parts were obviously completed and signed on the same day. At the foot, the form is witnessed by a member of the clinical team.

20.As In re A demonstrates, the ultimate question is whether X has, within the meaning of sections 44(1)(a) and 44(2) of the 2008 Act, "given a notice [in writing .. signed by [X]] stating that [X] consents to [X] being treated as the parent of any child resulting from treatment provided to [Y]." Now X has signed the Form WP, so the question reduces itself to this: in these circumstances, is the Form WP signed by both Y and X effective both as a notice given by Y in accordance with section 44(1)(b) to which the answer is plainly Yes and as a notice given by X in accordance with section 44(1)(a)?

21.This is not a question which in this precise form has arisen before. There is, unlike in many of the more recent cases I have had to consider, no case directly in point. So it has to be determined having regard to the principles to be extracted from the previous case-law, In re A in particular.

22.It is quite obvious that there has been a mistake. Whatever else X was doing, she was not signing the Form WP as Y's "representative". Y, after all, had signed herself. So what was X doing, what did she and Y and the witness think she was doing, when she signed the Form WP, if not to acknowledge and record that she was to be a legal parent?

23.The answer, in my judgment, is clear and obvious: X was signing the form, as Y's "partner" the word which in the relevant part of section 5 describes the capacity in which she was signing, and the word which appears in sections 2 and 3 and that can only have been to signify that, as section 3 spelt out, she (X) was to be a "legal parent." What otherwise, looking at the matter from Y's point of view, was the point of her partner X signing the document along with Y, what, looking at the matter from X's point of view, was the point of her signing the document along with Y, if not to record their joint acknowledgment that X was to be a parent? If X was not to be a parent, why did she sign the Form WP at all?

24.X is entitled to the declaration she seeks.

Outcome25.It was for these reasons that, at the conclusion of the hearing, I made a declaration in the terms sought by X.Costs26.The clinic has very properly agreed to pay X's reasonable costs. There is a dispute as to the appropriate amount. Both parties are content that I proceed immediately to a summary assessment.

27.The costs claimed by X's solicitors amount in all to some 25,000 net of VAT, the solicitors' costs amounting to 11,500 (being 46 hours charged at 250 per hour), counsel's fees amounting to some 13,360 (including some 36 hours work out of court), and other disbursements to 515.

28.Challenge is mounted to the solicitors' costs under three heads: (i) first, it is said that the Grade A Partner's hourly rate of 250 should be reduced to 217, the National grade 1 rate (the effect of this would be to reduce the sum of 11,500 to 9,982); (ii) next, it is said that a total of 6 hours should be charged at a Grade C rate of 161 (the effect of this would be to reduce the amount claimed by a further 364); (iii) finally, it is said that a number of letters and emails have been charged a full hour each. Counsel's fees are challenged on three points: (i) first, in relation to 8 hours spent researching and reading the authorities; (ii) next, in relation to 6 hours spent compiling the index to and preparing the bundle of authorities; (iii) finally, in relation to 4 hours drafting the case summary and skeleton argument.

29.Putting these specific points in context, Ms Cayoun says that the experience of those instructing her is that in cases such as this (they have been involved before me in Cases P, Q, R, S, T and U) the costs associated with such applications are "routinely" in the region of 10,000 15,000 (inclusive of VAT). She suggests that on this basis the clinic would have expected the costs to be about 12,500 (inclusive of VAT). As against that, it is to be noted that the costs in these cases are sometimes much higher: see, for example, Re the Human Fertilisation and Embryology Act 2008 (Cases F and H) (No 2) [2017] EWHC 964 (Fam) and Re the Human Fertilisation and Embryology Act 2008 (Case N) (No 2) [2017] EWHC 965 (Fam).

30.Despite Ms Cayoun's attractively, and moderately, presented submissions, I propose to assess the cost summarily in the sums claimed.

31.Given the enhanced degree of 'client care' that all these cases require, and this case, in particular, demanded, the solicitor's hourly charging rate of 250 was, in my judgment, entirely reasonable. Having regard to all the circumstances, and to the realities of practice in a small firm, the fact that the partner did various things which in a larger firm (probably charging significantly more) would have been delegated to a Grade C is not, in my judgment, any reason for reducing this part of the bill. So far as concerns the basis of charging in relation to letters and emails, the bill, as I read it, records not the number of letters (emails) but the number of hours' work involved. No doubt there is an element of 'rounding' here but nothing, in my judgment, which requires adjustment to the bill.

32.So far as concerns counsel's fees, it is important to emphasise, as I have already noted, that this case raised a point which had not arisen before; this was not, as in many of the other cases I have had to consider, a case 'on all fours' with some previous case. In these circumstances, it was obviously necessary for counsel to examine, with care, what is now a substantial volume of decisions, in order (a) to be sure that there was not, in fact, any case directly in point and (b) to marshall the best arguments in favour of his client's case. Whilst not going so far as to suggest that 'no stone should be left unturned', the issues in these cases, and the potential life-long implications for both parent and child, are so important, so grave, that there can be no question of cutting corners. And the fact that, in the event, the judge has come to a conclusion without hesitation, cannot be read back to support any suggestion that much work was not required on the part of counsel, both in researching the law and in preparing a proper bundle of authorities for the assistance of the court. In all the circumstances there is, in my judgment, no justification for any adjustment.

Read the original post:
Re AK, Human Fertilisation and Embryology Act 2008 [2017] EWHC 1154 (Fam)-1 - Family Law Week

EXCLUSIVE: ‘Grey’s Anatomy’s’ Giacomo Gianniotti Talks Jo and DeLuca: ‘I See Them Having a Relationship’ – Entertainment Tonight

Greys Anatomy star Giacomo Gianniotti is hopeful that Dr. Andrew DeLuca will see happier days in the halls of Grey Sloan Memorial Hospital.

The 28-year-old actor discussed the future of the love triangle his character is currently entangled in with Jo (Camilla Luddington) and her ex, Alex (Justin Chambers). Over the course of the last season, DeLuca began developing strong feelings for Jo, and it appears theres a very real possibility for a deeper connection between the two doctors.

DeLucas attempts to confess his feelings to Jo havent gone so well for him, Gianniotti recently told ET. But personally speaking, I think he jumped the gun a little bit. Shes fresh out of this relationship [with Alex]. I think she just needs a little time to process everything. Its not necessarily that she doesnt have interest and feelings for DeLuca, but she needs some space.

RELATED: 'Grey's Anatomy' Casts DeLuca's Sister for Season 14

They were great friends before and confidantes during a traumatic moment in her life, he added. Theres definitely bonding that happened there regardless. I see them having some kind of a relationship, whether its love or friends.

Adding a wrinkle to Jo and DeLucas blossoming relationship is the return of Jos estranged husband, Dr. Paul Stadler (Matthew Morrison), whom viewers met briefly when Alex tailed him at a Seattle medical conference. Though Gianniotti remained mum when it came to specifics about Stadlers reappearance, which Morrison hinted would be a big role.

I think its a great storyline to explore, Gianniotti said of Morrisons reprisal. We saw him and his existence outside of Seattles Grey Sloan, so if he comes into our world, thats a whole other thing. Thats him meeting the other doctors. Thats him being involved in the lives of everybody, not just Jo, so it definitely raises the stakes having him around in that capacity.

As for DeLuca and Maggies (Kelly McCreary) short-lived romance, Gianniotti says that nothing on Greys is simple -- and he prefers it that way.

RELATED: 'Grey's Anatomy' Cast Kicks Off Season 14 With First Table Read

Its complicated is such a great way to describe a lot of the relationships on Greys Anatomy, he said. We didnt really get much closure, but theyve gotten to the point where they can work together and be in the same room and be cool. But yeah, theres definitely some things left unsaid on both sides.

But Gianniotti promises there will be real closure for the two, romantically, in the new season: We might see a resolution, but it might not be a resolution that you guys thought or hoped for. Its gonna be comical more than dramatic.

He also spoke about the show reaching the impressive 300th episode milestone, which will air as the seventh installment in season 14.

I dont see [the show] stopping anytime soon. The show is still growing very strong, he said, noting that Greys added new producers, new writers this season for a fresh take. Its going to be funnier and sexier and lighter. Were still going to give you the drama. Youre still going to need that tissue box, for sure, but we want our audience to have a little bit more fun this season and enjoy some of our characters being happy.

Greys Anatomy kicks off season 14 with a two-hour premiere on Thursday, Sept. 28 at 8 p.m. ET/PT on ABC.

SHARE ON FACEBOOK SHARE

See more here:
EXCLUSIVE: 'Grey's Anatomy's' Giacomo Gianniotti Talks Jo and DeLuca: 'I See Them Having a Relationship' - Entertainment Tonight

Anatomy of terror: What makes normal people become extremists … – New Scientist

Who and what are we fighting?

Reuters

By Peter Byrne

VERA MIRONOVA rides Humvee shotgun through Mosuls shattered cityscape. It is late January 2017. Iraqi prime minister Haider al-Abadi has just declared east Mosul liberated from three years of rule by Islamic State, or ISIS. Most jihadist fighters are dead or captured, or have crossed the Tigris to the west, digging in for a final stand. Left behind, biding their time, are snipers and suicide bombers.

Much of the population has fled to refugee camps on the outskirts. Those who stayed look lost and dazed. Men pull corpses out of houses destroyed by air strikes. Others cobble together street-corner markets, selling meat and vegetables imported from Erbil, 80 kilometres and another world away.

Few women are visible. Mironova stands out, dressed in combat trousers and a Harvard sweatshirt, wisps of blonde hair escaping her blue stocking hat. Despite travelling in an armoured car, shes clearly not a combatant. Shes a social scientist, and her job is not to fight, but to listen, learn and record.

Advertisement

We stop for breakfast at My Fair Lady, a ramshackle restaurant that was a favoured eatery of ISIS fighters. The Iraqi special forces soldiers accompanying us say it has the best pacha in town steaming bowls of sheep brains and intestines stuffed with rice, with slices of black, fatty tongue and boiled oranges. Mironova orders a pizza.

A week later, a suicide bomber detonates himself at the entrance to the packed restaurant, killing the owner and several customers.

The United States does not have a real counter-terrorism strategy, says Martha Crenshaw. Faced with continued waves of jihadist terror attacks, in the conflict zones of Syria and Iraq but also closer to home, the West seems at a loss to know what to do. Crenshaw is something like the doyenne of terrorism studies, with a half-century career studying the roots of terror behind her. She occupies an office at Stanford University just down the hall from Condoleezza Rice, the former US national security advisor who was an architect of the global war on terror declared after the attacks of 11 September 2001. There is a vast amount of money being thrown into the counter-terrorism system and nobody is in charge, Crenshaw says. We do not even know what success might look like. We are playing a dangerous game of whack-a-mole: terrorists pop up. We try to beat them down, hoping they will give up.

In July, al-Abadi was back in Mosul, this time to declare the final liberation of Iraqs second city. Near-saturation bombardment of the centre by the US Air Force and a casualty-heavy, house-by-house offensive led by Iraqi forces had eliminated most of the fighters holding the city where the leader of ISIS, Ab Bakr al-Baghdadi, had proclaimed its caliphate in 2014. The liberation came at a huge price. Mosul lies in ruins, and tens of thousands of civilians are dead or wounded. Almost one million residents have been displaced from their homes.

The price has been paid not just in Mosul. In June, 206 civilians were killed in bombings and other attacks carried out or inspired by ISIS in Iraq, Afghanistan, Syria, Egypt, Iran, Australia, Pakistan and the UK, where radicalised ISIS supporters murdered eight in an attack near London Bridge on 3 June. A couple of weeks earlier, on 22 May, a 22-year-old British Muslim named Salman Ramadan Abedi detonated an improvised bomb laden with nuts and bolts at the entrance to the Manchester Arena, killing himself and 22 others, many of them children.

Why? Religious fanaticism? Groundless hate? Perverted ideology? Victory in the war on terror requires us to know what and who exactly we are fighting.

After breakfast, we accompany Iraqi commandos into abandoned houses that had been used by ISIS, wary of booby traps. We stare into darkened, steel-barred rooms used as jails for sex slaves and kafirs, Muslims who fell afoul of ISIS. We inspect the labels on tin cans, torn cookie packaging and empty bottles of Scotch whisky.

The soldiers scoop up photographs, checkpoint passes and slips of paper with names and phone numbers. Mironova bags religious tracts written in Arabic and Russian. Many of ISISs foreign fighters in Iraq and Syria are Chechnyans and Tajiks. Someone hands Mironova a diary written in Russian. She reads out loud, translating a letter written by a woman to her jihadist lover.

We are made only for each other, our marriage is sealed in heaven, we are together in this life and the afterlife, God willing. When you left, I counted the days until I got you back, my beloved. Now you are going to the war again; you may be gone forever. I will count the days until we meet again, my beloved Zachary. Following the letter, the woman had penned a recipe for a honey cake that requires a creamy milk not obtainable in Iraq. Jihadists dream of comfort food, too.

During the 1980s, Marc Sageman worked as a case officer for the CIA, operating armed cells resisting the Soviet occupation of Afghanistan. Now a forensic psychiatrist specialising in criminality and terrorism, he has been investigating what makes a terrorist for decades.

In his 2004 book Understanding Terror Networks, Sageman examined the motivations of 172 jihadist terrorists as revealed primarily in court documents. His conclusions fitted with decades of jail interviews and psychological studies showing that terrorism is neither solely reducible to ideological or religious motivations, nor to personality disorders. Terrorism is not a personality trait, says Sageman. There is no such thing as a terrorist, independent of a person who commits an act of terror.

That presents a problem for efforts to profile, identify and interdict individuals at risk of turning to terrorism, a central plank of anti-radicalisation programmes such as the UKs Prevent strategy (see Nip it in the bud). Democratic societies cannot keep an eye on everyone, and what they are looking for may not even give any obvious sign of its existence.

Crenshaws influential paper The causes of terrorism, published in 1981, summed up decades of observations of terrorists and their organisations, ranging from 19th century Russian anarchists to Irish, Israeli, Basque and Algerian nationalists. The outstanding common characteristic of individual terrorists, she concluded, is their normality. In her 1963 book Eichmann in Jerusalem, political theorist Hannah Arendt noted the same thing about the banal Nazi concentration camp bureaucrat Adolf Eichmann.

The unremarkable Nazi bureaucrat Adolf Eichmann embodied the banality of evil

People who commit terrorist acts are usually embedded in a network of familial and friendship ties with allegiance to a closed group, be that tribal, cultural, national, religious or political. Historically, the conditions for the murder of innocents by terrorism or genocide have occurred when one group fears extinction by another group. Ordinary people are motivated to kill people by category through their own group identity.

Viewed from inside the group, that can seem rational: terrorists are brave altruists protecting the group from harm by powerful outsiders. Terrorist acts are warnings to the out-group, demanding that certain actions be taken, such as withdrawing a military occupation or ending human and civil rights abuses. Terrorism is a militarised public relations ploy to advance a grander scheme a political tactic, not a profession or an overarching ideology.

But the vast majority of people who might share the same sense of grievance or political goals are not motivated to kill and maim the innocent. Criminologist Andrew Silke at the University of East London has conducted many interviews with imprisoned jihadists in the UK. When I ask them why they got involved, the initial answer is ideology, he says. But if I talk to them about how they got involved, I find out about family fractures, what was happening at school and in their personal lives, employment discrimination, yearnings for revenge for the death toll of Muslims.

Yet this is not a popular view with counter-terrorism agencies, he says. The government does not like to hear that someone became a jihadist because his brothers were beaten up by police or air strikes blew up a bunch of civilians in Mosul. The dominant idea is that if we concentrate on, somehow, defeating the radical Islamicist ideology, we can leave all of the messy, complicated behavioural stuff alone.

Mironova trained as a mathematician, game theorist and behavioural economist. A fellow at the Harvard Kennedy School, she is one of few researchers to venture directly into combat zones to examine the roots of jihadist terror. Her work has been funded variously by the US National Consortium for the Study of Terrorism and Responses to Terrorism (START), George Soross Open Society Foundations, the United Nations and the World Bank.

During extended stays in Syria, Iraq and Yemen over the past five years, Mironova has built up trust networks in a politically diverse spectrum of insurgents, including radical and moderate jihadists and ISIS members and defectors. She moves easily through the clogged frontline check points surrounding Mosul with the permission of the Iraqi military. She stays close to her protectors, careful not to cross the ethical line of doing no harm that separates academic research from intelligence gathering.

We are playing a dangerous game of whack-a-mole with the terrorists

By seeing things through the eyes of the fighters, Mironova aims to model what drives them, and how their individual motivations affect group behaviours and vice versa. She reads Arabic, but employs local translators in the field. She interviews fighters and civilians in hospitals, refugee camps and on the front lines face to face and via telephone or Skype.

Iraq as a whole is mainly Shia, but Mosul is largely Sunni; ISIS practices an apocalyptic form of the Sunni faith in a region wracked by social and economic catastrophe. Many civilians in the areas under their control collaborate, willingly and unwillingly, with ISIS. Some share their houses with fighters. Some work in ISIS factories, building homemade rockets, cutting and welding steel for jail bars and armour plates for tanks. Some escape into refugee camps. Some marry fighters. Some join sleeper cells.

In The causes of terrorism, Crenshaw observed that it is often the children of social elites who first turn to terrorism, hoping to inspire the less-privileged masses to approve a radical change in the social order. Many Jihadist organisations are led by upper middle class intellectuals, often engineers. Al Qaedas leader Ayman al-Zawahiri is a medical doctor; Ab Bakr al-Baghdadi reportedly has a doctorate in Islamic studies.

But the work of Mironova and others shows that the local ISIS rank and file is more down-to-earth: disenfranchised people struggling to eke out a living for their families in war zones. Foreign fighters tend to be more ideologically driven, and most motivated by factors beyond group identity to make the ultimate sacrifice (see Devoted to the cause).

REUTERS/Alkis Konstantinidis

Some militants seek to avenge the deaths of friends and relatives from US drone attacks, Shia militias, Iraqi police or US and British special operations forces. But as the sex slaves and Scotch suggest, jihadist fighters do not focus exclusively on heavenly rewards, or even hatred or revenge. Not everyone wants to die. Jihadist brigades in Iraq seize oil and vehicles, which they transport to high demand markets in Syria seeking to maximise profits. They often distribute gains from their looting and business operations communally.

Many of their adherents are purely economic actors, recruited with offers of competitive salaries, health insurance and benefits paid to their families should they be killed in battle. Mironova surveyed a cohort of Iraqi women who had encouraged their husbands and sons to join ISIS in order to get better family living quarters. Some recruits just need a job.

In Iraq and Syria, there are more than 1000 radical Islamist, moderate Islamist, and non-sectarian brigades seeking to recruit militants to their brand of insurgency. In Mironovas models, their behaviour is determined by resource constraints, much as capitalist enterprises thrive and die. Groups compete to attract the best fighters. Those with low budgets may choose a radical religious line to attract foreign fanatics who are not as professional as fighters motivated by money, but will work for just room and board. Such models suggest that although the roots of violent jihadism might be expressed as religious fervour, they are anchored in more mundane, utilitarian and perhaps solvable causes.

When the politicians demonise ISIS as evil, hormones flood the brain with danger signals, says Hriar Cabayan. We forget how to think scientifically. We need to get inside the heads of ISIS fighters and look at ourselves as they look at us.

Cabayan runs the Pentagons Strategic Multilayer Assessment (SMA) programme. His counter-terrorism unit taps the expertise of a volunteer pool of 300 scientists from academia, industry, intelligence agencies and military universities. They convene virtually and physically to answer classified and unclassified questions from combatants, including special operations forces fighting ISIS in Syria and Iraq. The result is a steady stream of white papers largely concluding that the US counter-terrorism strategy decapitating insurgency leadership, bombing terrorist strongholds is counter-productive.

Reliable information on terrorist attacks and the effectiveness of counter-terrorist actions is hard to find. STARTs Global Terrorism Database, based at the University of Maryland, records details of terrorist incidents as reported by English-language media. It does not record counter-terrorist actions. Crunching event-based data from STARTs media sources can reveal statistical patterns in terrorist attacks, including how frequently certain groups attack, numbers of fatalities and types of targets and weapons involved. The Mapping Militant Organizations database, hosted at Stanford University, includes data relevant to the political environments that nurture terrorism, but also relies on English-only news reports and selected academic journals.

Neither database includes acts of terror committed by states, except for Islamic State. The definitional boundaries between insurgency and terrorism and state repression are vague. Militant actions directed against soldiers can be recorded as terrorism, while lethal police actions or government-initiated attacks on civilians are regarded as acts of war, or collateral damage, and so ignored.

Classified data is no more comprehensive: about 80 per cent of top-secret intelligence is drawn from open sources, including media reports. Raw data that contradicts policy or that tarnishes the military is often under-reported or ignored by field officers who are more concerned with living to fight another day. There is censorship, too: a recent investigation by Military Times reports that since 9/11, the Pentagon has failed to publicly report about a third of its air strikes in Iraq, Syria and Afghanistan, omitting an estimated 6000 strikes since 2014.

Relying on such imperfect sources can obscure the real motivations and root causes behind events. The problem is that the press usually has a completely wrong narrative about the perpetrators that is only corrected in the evidence presented at the trials, says Sageman. National Security Agency files leaked by Edward Snowden reveal that the NSA has trouble hiring Arabic and Pashtu speaking intelligence analysts who understand the cultures they monitor. Military intelligence agencies focus more on locating and killing terrorist suspects than on understanding sociological motivations.

Cabayan praises Mironovas brave style of research, and the data from the ground that it brings. At the SMA meeting in March this year, the question was whether the physical defeat of ISIS in Mosul would eliminate the threat. Sixty scientists, including Mironova, examined the problem from a variety of perspectives. Their unequivocal answer was no. Events so far bear out that prediction.

There is no easy solution to the problem of terrorism, says Cabayan, because neither terrorists nor counter-terrorists are entirely rational operators. The words rational and irrational make no sense, he says. People behave emotionally, illogically. Human societies are complex, adaptive systems with unpredictable, emergent properties.

Many strands of evidence now suggest that terrorist and counter-terrorist systems are a single system governed by feedback loops; the actions and tactics of one side continually evolve in response to the actions of the other, as in a wrestling match. From this perspective, ISISs trajectory can be calculated only retrospectively, in response to events.

It is an agile trajectory. Statistical models built around what is known of the frequency and casualty counts of insurgent and terrorist incidents in Syria and Iraq show the jihadists as Davids and conventional armies as lumbering Goliaths. The extremist groups can fragment and coalesce with relative ease: they are anti-fragile, strengthening under attack. They are not wedded to charismatic leaders, but are self-organising networks that can operate independently of a single node of control, and have a ready source of new personnel.

The complex, evolving nature of the groups suggests that the US strategy of increasing troop numbers in Iraq, Syria and Afghanistan wont protect against jihadism. That conclusion is borne out by studies of the effects of troop surges in Iraq in 2007 and Afghanistan in 2012, both of which appear to have increased terrorism. Real complex systems do not resemble static structures to be collapsed; they are flexible, constantly respun spider webs, in the words of a 2013 SMA study of insurgency.

Drone strikes aimed at decapitating terrorist cells are likely to fail too. A 2017 study by Jennifer Varriale Carson at the University of Central Missouri concluded that killing high-profile jihadists is counter-productive, if its main intention is a decrease in terrorism perpetrated by the global jihadist movement. In July 2016, The Georgetown Public Policy Review reported a statistically significant rise in the number of terrorist attacks [in Pakistan] occurring after the US drone program begins targeting a given province.

Human societies are complex, unpredictable, adaptive systems

The drone strikes follow laws of unintended consequences, says Craig Whiteside of the Naval Postgraduate School in Monterey, California. Killing a charismatic leader may inspire a potent posthumous charismatic appeal, or cause splintering that results in otherwise suppressed extreme factions rising in prominence.

The effects are felt in Manchester as well as Mosul. In her most recent book, Countering Terrorism, Crenshaw writes, Western military engagement has reinforced the jihadist narrative that Muslims everywhere are targeted. It may have made ISIS more determined to inspire rather than direct terrorism. Nor has military action blocked jihadist organisations [in Iraq and Afghanistan] from regrouping, regenerating, and expanding.

The evolving nature of the message means it is difficult to combat by broadcasting counter-narratives. Social networks ensure the message feeds back rapidly to disenfranchised sympathisers in the West (see Network effects). Data scientists from the Naval Postgraduate School have studied Twitter feeds from ISIS strongholds before and after the US began bombing them in late 2014. Before the bombing campaign, the tweets focused ire on near enemies: local mayors, imams, police and soldiers. As the bombs dropped, the tweets went international, calling for the destruction of Western governments and civilians.

During the next three years, ISIS fighters or ISIS-inspired lone wolves targeted innocents in Brussels, Paris, Orlando, San Bernardino, Nice, Manchester and London. Atmospheric changes in social media reflect changes in the ground-level politics of insurgency, and specifically a willingness to export terrorism abroad. In the words of the sister of Abedi, the Manchester attacker, he saw the explosives America drops on [Muslim] children in Syria, and he wanted revenge.

Terrorist groups are seldom defeated by military force; they either achieve political solutions, or they wither away because grievances are solved or dissipate, or they alienate their supporters through excess brutality. Conversely, the US-led bombings of civilians in Fallujah and Mosul in Iraq and Raqqa in Syria, and the atrocities now being committed by the Iraqi liberators against ISIS suspects and their families, risk creating a new round of Sunni grievances.

Peter Byrne

According to a Pentagon-funded meta study of public opinion polls taken during 2015 and 2016, the vast majority of Muslims in Iraq and Syria do not support ISIS. But those who do cite religion or ideology far less than social, economic and governance grievances. And in Mosul, the study said, 46 per cent of the population believed coalition air strikes were the biggest threat to the security of their families, while 38 per cent said ISIS was the greatest threat.

If Iraqs economic and social infrastructure continues to deteriorate, a global war on terror that has to date cost $4 trillion will continue and more civilian lives will be lost to jihadist attacks in the countries involved and the West. The Sunnis in Iraq have a genuine grudge, says Cabayan. They were left out of the Shia-dominated government that we set up; they are under attack, nobody is protecting them. We can and should provide off-ramps for defeated ISIS members safety, jobs, civil rights. If not, after the fall of Mosul, we will be facing ISIS 2.0.

The counter-productive strategies go both ways. The immediate effect of civilian casualties in terror attacks is generally to undermine the ability of the attacked population to perceive the grievances of the attacking group as genuine, and to strengthen the political desire to hit back militarily. Retired US Navy captain Wayne Porter was naval chief of intelligence for the Middle East from 2008 to 2011. He is convinced that the only solution to terrorism is to deal with its root causes.

The only existential threat to us from terrorist attacks, real or imagined, is that we stay on the current counter-productive, anarchically organised, money-driven trajectory, says Porter, who now teaches counter-terrorism classes to military officers at the Naval Postgraduate School. Our current counter-terrorism strategy, which is no strategy, will destroy our democratic values.

When ISIS is driven from west Mosul in July, Mironova is back on the battlefield, gathering more data about the fate of families accused of collaborating. Extrajudicial punishment of Sunnis by Shia and Kurdish forces is causing fear and resentment, and fuelling ISIS, which is far from defeated.

ISIS is like H2O. It can be in several states: ice, water and vapour, she says. In Mosul, it was ice. We melted it. Now it is water, flowing into the countryside, seizing towns. It can vaporise to live and fight another day.

ZUMA/REX/Shutterstock

What makes someone prepared to die for an idea? This is a question that concerns anthropologist Scott Atran of the University of Oxfords Centre for Resolution of Intractable Conflicts. Research he has led in some of the most embattled regions of the world, including in Mosul, suggests the answer comes in two parts. Jihadists fuse their individual identity with that of the group, and they adhere to sacred values.

Sacred values are values that cannot be abandoned or exchanged for material gain. They tend to be associated with strong emotions and are often religious in nature, but beliefs held by fervent nationalists and secularists, for example, may earn the label too. Atran has found that people in fighting groups who hold sacred values are perceived by other members of their group as having a spiritual strength that counts for more than their physical strength. Whats more, sacred values trump the other main characteristic of extremists: a powerful group identity. When push comes to shove, these fighters will desert their closest buddies for their ideals, he says.

Atran argues that individuals in this state of mind are best understood, not as rational actors but as devoted actors. Once theyre locked in as a devoted actor, none of the classic interventions seem to work, he says. But there might be openings. While a sacred value cannot be abandoned, it can be reinterpreted. Atran cites the case of an imam he interviewed who had worked for ISIS as a recruiter, but had left because he disagreed with their definition of jihad. For him, but not for them, jihadism could accommodate persuasion by non-violent means.

As long as such alternative interpretations are seen as coming from inside the group, Atran says, they can be persuasive within it. He is now advising the US, UK and French governments on the dynamics of jihadist networks to help them tackle terrorism. Laura Spinney

Deradicalisation programmes are the bedrock of counter-terrorism strategies in many countries. They aim to combat extremism by identifying individuals who have become radicalised, or are in danger of becoming so, and reintegrating them to the mainstream using psychological and religious counselling as well as vocational training.

In the UK, some 4000 people are reported to the governments anti-terror programme Prevent every year. The majority 70 per cent are suspected Islamic extremists, but about a quarter are far-right radicals, and that number is growing.

Critics fear that these programmes criminalise and stigmatise communities, families and individuals. In addition, there are questions about who governments collaborate with for information and whether public servants should be obliged to report potential radicals.

There is also very little evidence that the programmes work. Most fail to assess the progress of participants, and rates of recidivism are rarely studied. In a recent report, the UK parliaments human rights committee warned that the governments counter-extremism strategy is based on unproven theories and risks making the situation worse.

The key to combating extremism lies in addressing its social roots, and intervening early, before anyone becomes a devoted actor willing to lay down their lives for a cause, says Scott Atran at the University of Oxfords Centre for Resolution of Intractable Conflicts (see Devoted to the cause). Until then, there are all sorts of things you can do. One of the most effective counter measures, he says, is community engagement. High-school football and the scouts movement have been effective responses to antisocial behaviour among the disenfranchised children of US immigrants, for example.

Another promising avenue is to break down stereotypes, says social psychologist Susan Fiske at Princeton University. These are not necessarily religious or racial stereotypes, but generalised stereotypes we all hold about people around us. When we categorise one another, we are particularly concerned with social status and competition, viewing people of low status as incompetent, and competitors as untrustworthy. Throughout history, violent acts and genocides have tended to be perpetrated against high-status individuals with whom we compete for resources, and who therefore elicit our envy, says Fiske.

Fiskes group has found ways to disrupt stereotypes by making people work together to achieve a common goal, for example. Trivial contact involving food, festivals and flags wont cut it, she says. It has to be a goal people care about and are prepared to invest in, such as a work project or community build. Here, success depends on understanding the minds of your collaborators rehumanising them.

Changing perspectives Tania Singer of the Max Planck Institute for Human Cognitive and Brain Sciences in Leipzig, Germany, thinks brain training could achieve similar effects. Social neuroscientists have identified two pathways in the brain by which we relate to others. One mobilises empathy and compassion, allowing us to share another persons emotions. The second activates theory of mind, enabling us to see a situation from the others perspective.

Singers group recently completed a project called ReSource, in which 300 volunteers spent nine months doing training, first on mindfulness, and then on compassion and perspective taking. After just a week, the compassion training started to enhance prosocial behaviours, and corresponding structural brain changes were detectable in MRI scans.

Compassion evolved as part of an ancient nurturing instinct that is usually reserved for kin. To extend it to strangers, who may see the world differently from us, we need to add theory of mind. The full results from ReSource arent yet published, but Singer expects to see brain changes associated with perspective-taking training, too. Only if you have both pathways working together in a coordinated fashion can you really move towards global cooperation, she says. By incorporating that training into school curricula, she suggests, we could build a more cohesive, cooperative society that is more resilient to extremism. Laura Spinney

A key feature of jihadist groups is their use of social networks to propagate their ideas. If you can disrupt those connections, thats probably your best shot at stopping people from becoming terrorists, says J. M. Berger at the International Centre for Counter-Terrorism in The Hague and co-author of ISIS: The state of terror.

He believes that the advent of social media has not only increased the number of people extremist groups can reach, but also the potency of their message, because it allows them to circumvent safeguards against revisionism and hate speech. Those most susceptible to the propaganda, his research suggests, are not the chronically poor or deprived, but people experiencing uncertainty in their lives recent converts, young people who have just left the family home, those with psychiatric problems.

Extremist groups are adept at fomenting collective uncertainty, for example by provoking hostility between ethnic groups. At the same time, they present themselves as upholders of clear and unwavering values, an attractive message to individuals who are undergoing potentially destabilising transformations. Through social networks, those experiencing uncertainty can learn about and even enter into contact with extremist networks.

The G7 recognised this with its recent statement that it will combat the misuse of the internet by terrorists. But this is easier said than done, says Berger. Its easy to demand social media companies do something about extremism, but much harder to define what they should do in a way that is consistent with the values of liberal democracies. Laura Spinney

This article appeared in print under the headline Roots of terror

Leader: To tackle extremism, we need to know the enemy

More on these topics:

Read the original here:
Anatomy of terror: What makes normal people become extremists ... - New Scientist

New ‘Grey’s Anatomy’ Season 14 Photo Will Keep Fans Guessing – People’s Choice

Johnni Macke 11:17 am on August 17, 2017

(Photo Courtesy: ABC)

The stars ofGreys Anatomy have been teasing the upcoming season since the beginning of August, and now the production team behind the amazing medical drama is jumping in on the fun by giving fans a first look at whats coming up.

While the cast members who make up everyones favorite TV doctors (including Ellen Pompeo, Jesse Williams, Sarah Drew, and more) have been reuniting and sharing on-set pictures for weeks, Shondaland TV (aka Shonda Rhimes production company) has been keeping the new season under wrapsuntil now!

Whos excited for the 14th season of #GreysAnatomy? #shondaland, the production company wrote on Instagram on Wednesday (Aug. 16), along with a behind-the-scenes first look at scene from the new season.

Besides confirming that filming for season 14 is well underway, the photo gives fans a glimpse at a scene from the upcoming two-hour premiere episode while offering just enough clues to keep fans guessing about whats really going on in the scene in question.

In the photo, we can see that there are three people lined up at the hospital (one of whom appears to be Meredith Grey?). Are 0ur favorite docs presenting a united front? Or are we actually looking at a new batch of interns? More importantly, why isnt anyone wearing a lab coat? The photo purposefully keeps things vague.

According to the slate seen in the pic, episode will be directed by Debbie Allen (who has acted on the series since 2011). The premiere will mark the 15th episode shes directed for the series to date.

As previously reported, Greys alum, Krista Vernoff, who is returning to the series as itsshowrunner, wrote the season 14 premiere episode, so clearly there is a LOT of star power both in front of the camera and behind it for this kickoff episode.

Greys Anatomy returns with a two-hour premiere for its 14th season on September 28, 2017 at 8 p.m. on ABC.

For the latest pop culture news and voting, make sure to sign up for the Peoples Choice newsletter!

See original here:
New 'Grey's Anatomy' Season 14 Photo Will Keep Fans Guessing - People's Choice

Grey’s Anatomy: What does Shondaland’s move mean for the show’s future? – EW.com

With Shonda Rhimes now moving Shondaland to Netflix, should fans be worried about the future of Greys Anatomy?

On Sunday, it was announced that Rhimes has signed a multi-year deal with Netflix, moving her production company from ABC to the streamer. Heres the good news: Rhimes move will not affect Greys, Scandal, How to Get Away With Murder, midseason legal entry For the People, or the upcoming Greys Anatomy spin-off. As long as those shows are on the air, they will air on ABC, and Rhimes/Shondaland will still be involved with their production.

But how much life is left in the veteran medical drama, which is heading into its 14th season this fall? ABC chief Channing Dungey had previously expressed hope that Greys would outlive NBCs stalwart medical series ER, which ran for 15 seasons. Thatd be lovely, Dungey told EW in January. Ill take even more! Honestly, I think that the show is going to continue as long as Shonda and the gang have a creative passion for telling those stories. At the moment, it feels like were full steam ahead.

ABC sources say that hope has not changed in the wake of Rhimes move. Shondaland sources, meanwhile, are confident Greys Anatomy will continue to air on ABC for a very long time to come. In other words, Greys Anatomy wont be ending any time soon.

Greys Anatomy will return with a two-hour premiere on Thursday, Sept. 28 at 8 p.m. ET on ABC.

More here:
Grey's Anatomy: What does Shondaland's move mean for the show's future? - EW.com

Biochemistry and dodgy bros: How I came to love a new wine – Prospect

In Australia, good winemakers find something in Grenache that just doesnt seem to show in any other part of the worldby Barry Smith/ August 15, 2017 /Leave a commentPublished in September 2017 issue of Prospect Magazine

Ive never really liked Grenache. Wines made from this grape typically combine a sweetly floral aroma with a juicy tartness that is just on the edge for me. Nothing seems to bridge the heady aroma and the crunchy strawberry fruit.

But then I discovered what could be done with this variety. After recent tastings in McLaren Vale, south of Adelaide, I now believe that it could be Australias best grape. There, good winemakers find something in Grenache that just doesnt seem to show in any other part of the world.

I learned this from Wes Pearson, a maverick Canadian now settled in the soils of South Australia. By day, he is a biochemist at the Australian Wine Research Institute, and at other times he makes wine. He buys in grapes, picked just ahead of ripeness to avoid that jammy character found in some Australian reds. His entry-level wines are bottled under his Juxtaposed labels with cinematic characters portrayed in lurid colours. These include a Fiano white wine, called Bigger boat after Roy Scheiders famous line from Jaws. Theres a Pinot Meunier ros, with bite and character. In the reds there are Sangioveses Grenaches and Shirazes as well as unfamiliar blends such as that of Grenache and Tempranillo. The finer wines are under the label of Dodgy Bros. Despite the name, they are poised wines with depth, and the best of them was the 2014 Archetype Grenache. An almost old world nose, rich in the mouth, balanced, with a cherry-like finish restrained by fine bitterness. Fine, opulent and utterly delicious.

YOU'VE HIT THE LIMIT

You have now reached your limit of 3 free articles in the last 30 days.But don't worry! You can get another 7 articles absolutely free, si mply by entering your email address in the box below.

When you register we'll also send you a free e-book-Writing with punch-which includes some of the finest writing from our archive of 22 years. And we'll also send you a weekly newsletter with the best new ideas in politics and philosophy of culture, which you can of course unsubscribe from at any time

Prospect takes your privacy seriously. We promise never to rent or sell your e-mail address to any third party.You can unsubscribe from the Prospect e-mail newsletter at any time.

Read more from the original source:
Biochemistry and dodgy bros: How I came to love a new wine - Prospect

Linking seizures, heart health and sleeping sickness to bacteria and shape-shifting parasites in the mouth and gut – UB News Center

BUFFALO, N.Y. Four studies focused on improving ourunderstanding of the human genome and microbiome were awardedfunding through the third round of research pilots supported by theUniversity at Buffalos Community of Excellence in Genome,Environment and Microbiome (GEM).

The projects, which total $150,000, will study how therelationship between the human body and the collection ofmicroorganisms that reside on or within it affect our risk forcertain diseases.

Understanding the connection these microorganisms have with ourbodies may enable the development of precision medicine and empowerindividuals to have greater control over their health.

The pilot grants award researchers from a variety of disciplinesup to $50,000 to develop innovative projects focused on themicrobiome. The funds support up to one year of research.

The awards are provided through GEM, an interdisciplinarycommunity of UB faculty and staff dedicated to advancing researchon the genome and microbiome. GEM is one of UBs threeCommunities of Excellence, a $9 million initiative to harness thestrengths of faculty and staff from fields across the university toconfront the challenges facing humankind through research,education and engagement.

Changes in the genome our own or those of themicrobes in, on or around us have a tremendous impact onhuman health and our environment, says Jennifer Surtees,PhD, GEM co-director and associate professor in the Department ofBiochemistry in the Jacobs School of Medicine and BiomedicalSciences at UB.

With these newest projects, UB scientists from acrossdisciplines have come together to dig deeper into these changes andto help establish the infrastructure necessary for advancedprecision medicine.

Along with Surtees, GEM is led by Timothy Murphy, MD, executivedirector and SUNY Distinguished Professor in the UB Department ofMedicine; and Norma Nowak, PhD, co-director, professor in theDepartment of Biochemistry, and executive director of UBsNew York State Center of Excellence in Bioinformatics and LifeSciences.

The funded projects involve faculty teams from the Jacobs Schoolof Medicine and Biomedical Sciences, the UB School of Public Healthand Health Professions, and the UB School of Dental Medicine.

Can organisms in the gut increase vulnerability toseizures?

Inflammation in the central nervous system can increasesusceptibility to seizures.

Given the role that the intestinal microbiome plays in shapinginflammation in the body, UB researchers believe that the tinyorganisms may have an impact on the onset, strength and duration ofseizures.

The study, led by Ira J. Blader, PhD, professor in the UBDepartment of Microbiology and Immunology, and Alexis Thompson,PhD, senior research scientist in the UB Research Institute onAddictions, will examine in mice the composition of the microbiomeand which of its components affect seizures.

If correct, this may suggest the gut microbiome as a therapeutictarget for the treatment of seizures and epilepsy.

Researchers lay groundwork for UB genomic research with SpitFor Buffalo

To better understand how the human genome and microbiomeinteract to influence health, UB researchers will establish SpitFor Buffalo, a project that will collect DNA samples from volunteerUBMD patients for use in future studies.

The researchers will collect saliva samples, anonymously linkthe samples to each patients electronic medical record, andsequence the genome and oral microbiome. By determining which genesare associated with which diseases, new connections betweenspecific genes and diseases will be made.

Samples are currently being collected from patients in the UBMDNeurology, Internal Medicine and OBGYN clinics in the ConventusCenter For Collaborative Medicine.

The project will provide an infrastructure resource for genomeand microbiome investigations at UB.

The research is led by Richard M. Gronostajski, PhD, professorin the Department of Biochemistry and director of both the WNY StemCell Culture and Analysis Center and the Genetics, Genomics andBioinformatics Graduate Program; Gil I. Wolfe, MD, professor andIrvin and Rosemary Smith Chair of the UB Department of Neurology;Michael Buck, PhD, associate professor in the Department ofBiochemistry and director of the WNY Stem CellSequencing/Epigenomics Center; and Nowak.

Solving how RNA provides a parasite with shape-shiftingabilities

The parasite Trypanosoma brucei, the cause of HumanAfrican Trypanosomiasis commonly known as sleeping sickness radically alters its physiology and morphology as it movesbetween insect and mammal over the course of its life cycle.

These changes, researchers found, are caused by various RNAbinding proteins, allowing the organism to survive in environmentsthat range from the human bloodstream to the insect gut. UBresearchers will examine how these proteins regulate theparasites transformations.

The study is led by Laurie K. Read, PhD, professor in theDepartment of Microbiology and Immunology; and Jie Wang, PhD,research assistant professor in the Department of Biochemistry.

Pinpointing the potential effects of oral and gut bacteria onheart health

UB researchers will investigate the connection between oral andgut bacteria and the onset and progression of atheroscleroticcardiovascular disease (CVD), or the buildup of plaque around theartery walls, eventually blocking blood flow.

The study will seek to understand how the microbes in the bodycontribute to plaque formation in the arteries, providing the basisfor interventions that reduce the effects of the microorganisms onCVD.

Previous studies have found microbes present in arterialplaques, but have not provided conclusive links to the parts of thebody where the microbes originate. Researchers will usenext-generation sequencing and advanced bioinformatics analysismethods to identify and characterize microorganisms in the arterywalls and compare the bacteria with those present in oral, gut andskin microbiomes.

Environmental factors such as smoking, blood cholesterol andperiodontal disease status will also be examined as potentialfactors that influence the bacteria-CVD relationship.

The research is led by Robert J. Genco, DDS, PhD, SUNYDistinguished Professor in the UB Department of Oral Biology andDepartment of Microbiology and Immunology, and director of the UBMicrobiome Center; and Michael J. LaMonte, PhD, research associateprofessor in the UB Department of Epidemiology and EnvironmentalHealth.

See more here:
Linking seizures, heart health and sleeping sickness to bacteria and shape-shifting parasites in the mouth and gut - UB News Center